Browsing Tag
NASDAQ
289 posts
SOL Strategies’ C$30m raise fuels a massive Solana accumulation — What investors should know before Nasdaq debut
Find out how SOL Strategies used a C$30M raise to buy 88,433 SOL tokens and expand its treasury ahead of its Nasdaq debut as ticker STKE.
Why did Sellas Life Sciences file to register 19.69m shares, and how could this affect SLS stock performance in 2025?
Sellas registers 19.69 M shares for resale after a warrant deal. Discover what it means for dilution, stock sentiment, and upcoming biotech catalysts.
House of Doge to list on NASDAQ through merger with Brag House, marking Dogecoin’s entry into the public market
Find out how House of Doge’s merger with Brag House brings Dogecoin into the NASDAQ spotlight and what it means for crypto’s Wall Street future.
Is Nasdaq the new home for fashion brands? Vince Holding’s 12% rally says yes
See why Vince Holding (NYSE: VNCE) plans to shift its U.S. listing to Nasdaq, triggering a 12% rally and signaling a fresh market rebranding.
ARC Group commits up to $50m to ScanTech AI Systems, fueling AI-driven security and Nasdaq comeback
Discover how ARC Group’s $50M financing could reshape ScanTech AI’s path to Nasdaq compliance and AI-driven security dominance.
Prestige Wealth’s $150m move could make Aurelion NASDAQ’s first Tether Gold-powered treasury
Find out how Prestige Wealth’s $150 million Aurelion financing could transform it into NASDAQ’s first Tether Gold-powered digital treasury.
Bollinger Innovations leaves Nasdaq: Is this bold OTC leap a comeback or collapse?
Bollinger Innovations (NASDAQ: BINI) is leaving Nasdaq for OTC Markets on October 13 — a high-stakes reset for the loss-making EV manufacturer.
Inside Shuttle Pharmaceuticals’ $10m AI gamble: How Molecule.ai could rewrite drug discovery timelines
Shuttle Pharmaceuticals to acquire Molecule.ai for $10M, entering AI-driven drug discovery. See how this bold move could reshape SHPH’s biotech future.
Can NeoVolta’s Neubau Energy deal make modular home batteries the next big clean-tech revolution?
NeoVolta (NASDAQ: NEOV) acquires Neubau Energy assets to cut installation time and boost margins. Learn how this move could reshape home battery storage.
Turn Therapeutics expands its float with 7 million shares up for sale — should retail investors be cautious?
Turn Therapeutics (NASDAQ: TTRX) registers 7 million shares for resale by insiders post-direct listing. Learn how this impacts investors, liquidity, and stock sentiment.